Feasibility
deaths
DISEASE
Study personnel were easily able to identify suitable patients. Given the relentless and fatal nature of the disease, patients were eager to participate in the study. Although no efficacy outcomes were promised, of 19 patients screened, 18 were enrolled. The study team was able to maintain contact with all the subjects and all subjects completed the study, apart from the below described non-SVF-related deaths. The study team was able to collect the protocol-specified data in a timely and complete manner.